Literature DB >> 23017136

Immune suppression: the hallmark of myeloid derived suppressor cells.

Lydia A Haile1, Tim F Greten, Firouzeh Korangy.   

Abstract

Myeloid derived suppressor cells (MDSC) are heterogeneous cell population consisting of myeloid progenitor cells and immature myeloid cells. These cells have essential immunoregulatory role in tumor bearing hosts and under different inflammatory conditions. No specific marker has been described to identify MDSC, which leaves their suppressor activity as their only hallmark function. In this review, we discuss the current in vivo and in vitro developed assays for elucidation of MDSC function and describe the discrepancies between murine and human MDSC in regard to their suppressor function. We also discuss antigen specificity of MDSC function and approaches to determine the effector function of these cells in vivo. Finally, we summarize different approaches currently being employed to target MDSC with the aim to enhance immune based therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017136      PMCID: PMC6309556          DOI: 10.3109/08820139.2012.680635

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  22 in total

1.  Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.

Authors:  Su Jong Yu; Chi Ma; Bernd Heinrich; Zachary J Brown; Milan Sandhu; Qianfei Zhang; Qiong Fu; David Agdashian; Umberto Rosato; Firouzeh Korangy; Tim F Greten
Journal:  J Hepatol       Date:  2018-11-09       Impact factor: 25.083

2.  The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cells.

Authors:  Edwin Garzón; Philippe Holzmuller; Rachel Bras-Gonçalves; Philippe Vincendeau; Gérard Cuny; Jean Loup Lemesre; Anne Geiger
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

3.  Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.

Authors:  Tamar Kapanadze; José Medina-Echeverz; Jaba Gamrekelashvili; Jonathan M Weiss; Robert H Wiltrout; Veena Kapoor; Nga Hawk; Masaki Terabe; Jay A Berzofsky; Michael P Manns; Ena Wang; Francesco M Marincola; Firouzeh Korangy; Tim F Greten
Journal:  Eur J Immunol       Date:  2015-02-23       Impact factor: 5.532

4.  An interleukin-1 beta-encoding retrovirus exhibits enhanced replication in vivo.

Authors:  Edward P Browne
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

5.  The significant increase and dynamic changes of the myeloid-derived suppressor cells percentage with chemotherapy in advanced NSCLC patients.

Authors:  S Wang; Y Fu; K Ma; C Liu; X Jiao; W Du; H Zhang; X Wu
Journal:  Clin Transl Oncol       Date:  2013-11-06       Impact factor: 3.405

Review 6.  Transcriptional regulation of myeloid-derived suppressor cells.

Authors:  Thomas Condamine; Jérôme Mastio; Dmitry I Gabrilovich
Journal:  J Leukoc Biol       Date:  2015-09-03       Impact factor: 4.962

7.  Heterogeneity of Ly6G+ Ly6C+ Myeloid-Derived Suppressor Cell Infiltrates during Staphylococcus aureus Biofilm Infection.

Authors:  Cortney E Heim; Sean C West; Hesham Ali; Tammy Kielian
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

Review 8.  Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?

Authors:  Celeste Goh; Sowmya Narayanan; Young S Hahn
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

9.  p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.

Authors:  Cristina Saiz-Ladera; María Fernanda Lara; Marina Garín; Sergio Ruiz; Mirentxu Santos; Corina Lorz; Ramón García-Escudero; Mónica Martínez-Fernández; Ana Bravo; Oscar Fernández-Capetillo; Carmen Segrelles; Jesús M Paramio
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

Review 10.  Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies.

Authors:  Alejandro Olivares-Hernández; Luis Figuero-Pérez; Eduardo Terán-Brage; Álvaro López-Gutiérrez; Álvaro Tamayo Velasco; Rogelio González Sarmiento; Juan Jesús Cruz-Hernández; José Pablo Miramontes-González
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.